TrialBMC pulmonary medicine2014

Randomized study of the safety, pharmacokinetics, and bronchodilatory efficacy of a proprietary glycopyrronium metered-dose inhaler in study patients with chronic obstructive pulmonary disease.

Stephen Rennard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.